Literature DB >> 8844583

Fatal experimental equine arteritis virus infection of a pregnant mare: immunohistochemical staining of viral antigens.

N J MacLachlan1, U B Balasuriya, P V Rossitto, P A Hullinger, J F Patton, W D Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844583     DOI: 10.1177/104063879600800316

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


× No keyword cloud information.
  16 in total

1.  Equine Arteritis Virus Has Specific Tropism for Stromal Cells and CD8+ T and CD21+ B Lymphocytes but Not for Glandular Epithelium at the Primary Site of Persistent Infection in the Stallion Reproductive Tract.

Authors:  Mariano Carossino; Alan T Loynachan; Igor F Canisso; R Frank Cook; Juliana R Campos; Bora Nam; Yun Young Go; Edward L Squires; Mats H T Troedsson; Thomas Swerczek; Fabio Del Piero; Ernest Bailey; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Development and characterization of an infectious cDNA clone of the modified live virus vaccine strain of equine arteritis virus.

Authors:  Jianqiang Zhang; Yun Young Go; Chengjin M Huang; Barry J Meade; Zhengchun Lu; Eric J Snijder; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2012-06-27

3.  Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes.

Authors:  Yun Young Go; Jianqiang Zhang; Peter J Timoney; R Frank Cook; David W Horohov; Udeni B R Balasuriya
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Equine Arteritis Virus Elicits a Mucosal Antibody Response in the Reproductive Tract of Persistently Infected Stallions.

Authors:  Mariano Carossino; Bettina Wagner; Alan T Loynachan; R Frank Cook; Igor F Canisso; Lakshman Chelvarajan; Casey L Edwards; Bora Nam; John F Timoney; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

5.  Downregulation of MicroRNA eca-mir-128 in Seminal Exosomes and Enhanced Expression of CXCL16 in the Stallion Reproductive Tract Are Associated with Long-Term Persistence of Equine Arteritis Virus.

Authors:  Mariano Carossino; Pouya Dini; Theodore S Kalbfleisch; Alan T Loynachan; Igor F Canisso; Kathleen M Shuck; Peter J Timoney; R Frank Cook; Udeni B R Balasuriya
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

Review 6.  Equine viral arteritis.

Authors:  N James MacLachlan; Udeni B Balasuriya
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

7.  Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.

Authors:  U B Balasuriya; H W Heidner; J F Hedges; J C Williams; N L Davis; R E Johnston; N J MacLachlan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Genetic typing of equine arteritis virus isolates from Argentina.

Authors:  María Gabriela Echeverría; Silvina Díaz; Germán Ernesto Metz; María Soledad Serena; Carlos Javier Panei; Edgardo Nosetto
Journal:  Virus Genes       Date:  2007-02-09       Impact factor: 2.332

9.  Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test.

Authors:  Yun Young Go; Susan J Wong; Adam J Branscum; Valerie L Demarest; Kathleen M Shuck; Mary L Vickers; Jianqiang Zhang; William H McCollum; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

10.  Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor.

Authors:  Sanjay Sarkar; Lakshman Chelvarajan; Yun Young Go; Frank Cook; Sergey Artiushin; Shankar Mondal; Kelsi Anderson; John Eberth; Peter J Timoney; Theodore S Kalbfleisch; Ernest Bailey; Udeni B R Balasuriya
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.